Viral Vector Manufacturing Market Anticipated to Grow at a CAGR of 17.5% by 2022
The global market for viral vector vaccine manufacturing is expected to increase from $22.9 million in 2017 to nearly $51.2 million in 2022 at a compound annual growth rate (CAGR) of 17.5% for 2017-2022.
View full press release